Each 5mmHg reduction in systolic blood pressure lowered the relative risk of cardiovascular events by around 10%. Authors, Kazem Rahimi et al, call for changes to global guidelines. hubs.li/H0MhDYV0 2/2

In anticipation of #ASE21 this weekend, we'd like to share this AI on #EchoFirst. This frame-to-frame measurement of PLAX was fully automated by EchoNet-LVH. More examples and preprint soon! American Society of Echocardiography Cedars-Sinai

Is raised #bloodpressure (BP) an inevitable and essential process of ageing is it time to remove #hypertension from our vocabulary and manage #CVD risk irrespective of an individual's BP into very old age? doi.org/10.1016/S0140-… doi.org/10.1016/S0140-… #ESCCongress The Lancet

So proud to have lectured today at #ESCCongress about SGLT2i! Thanks for the invitation, European Society of Cardiology! Session: Meet the Experts: fuel up! – targeting cardiac energy metabolism in type 2 diabetes and HF… Title: ... By Pharmacological Interventions: SGLT2i in heart failure

First come first serve for #euroecho on-site in Berlin. Limited number of seats. #eacvi This is one get his inscription! European Society of Cardiology Alessia Gimelli Denisa Muraru Matteo Cameli, MD, PhD Steffen Petersen Thor Edvardsen @MarcDweck Julia Grapsa MD, PhD EACVI President

Stress FR during LDDSE is useful for the detection of AS severity & flow reserve & is associated with outcomes following aortic valve intervention Anastasia Vamvakidou Philippe Pibarot Ezequiel Guzzetti MD 🇦🇷🇨🇦 Philipp E. Bartko Stefan Orwat João Cavalcante Jutta Bergler-Klein Chetan Shenoy #AHAJournals ow.ly/cZZw50GIioZ

Ever thought of preventing aortic stenosis (AS) instead having AVR or TAVI? Molecular mechanisms are unravelled and we will prevent AS like CAD. Statins do not work, but Lp(a) is a target in some, in others molecular mechanisms are deciphered - read it in the EHJ online!

"Unsupervised clustering supports the association of sMR with mortality predominantly driven by the small LV cavity phenotype, as previously suggested by a conceptional framework and termed disproportionate sMR" jacc.org/doi/10.1016/j.…

The association of secondary MR with mortality cannot be purely attributed to cardiac morphology alone. From @jaccjournals jacc.org/doi/10.1016/j.…

What are the key morphological and functional features in secondary mitral regurgitation? Philipp E. Bartko, Gregor Heitzinger, Georg Goliasch et al from our Structural Heart Vienna group present exciting novel data in JACC Journals jacc.org/doi/10.1016/j.…

Topological mapping in secondary MR (sMR): #echofirst analysis shows importance of role of LA. Highest mortality in “small LV cavity” cluster. bit.ly/3GqrwiW #vhdMR #cvVHD #JACCIMG #CardioTwitter #cvImaging #HFrEF Structural Heart Vienna Philipp E. Bartko Gregor Heitzinger Georg Goliasch

Excited to announce that my new provocative maneuver to detect PFO using party balloon during Saline Contrast Transthoracic Echocardiography has been published in JACC: Case Reports. jacc.org/doi/10.1016/j.…

Tricuspid regurgitation: what have we learnt? #EHJCVI 🚩 New nomenclature 🚩 New classification 🚩 New grading 🚩 New imaging approaches doi.org/10.1093/ehjci/… Fantastic leadership by RTHahnMD &collaboration Luigi francesco maisano Philipp E. Bartko Donal JL Zamorano #PCRTricuspid

Thank you to my co-authors Luigi Denisa Muraru Philipp E. Bartko francesco maisano PEPE ZAMORANO and Donal: TR Review bit.ly/EHtJCVI_TRRevi… European Society of Cardiology Journals European Society of Cardiology American Society of Echocardiography Vladyslav Kavalerchyk 🇺🇦 Enrique Garcia-Sayan, MD, FACC, FASE Roberto M Lang

GDMT titration conveys 3x higher chance to achieve improvement in secondary MR. 40% pts achieved #SMR reduction w/ ARNi and combinations of RASi, BB & MRA Congrats Philipp E. Bartko Georg Goliasch doi.org/10.1093/ehjci/… #EHJCVI European Society of Cardiology Journals @GeraldMaurer

Im Rahmen der Langen Nacht der Forschung können Sie eine von unseren Kardiologie MedUni Wien Forschung ExpertInnen live-kommentierte minimal-invasive Herklappen-Implantation verfolgen! Fr 20.5. 18:00 MedUni Wien / AKH Hörsaalzentrum langenachtderforschung.at/station/1392

Join Edwards Lifesciences in Paris or online for their #EuroPCR 2022 symposiums: ➡️"Valve in Valve and the journey starting with the first prosthesis" with Structural Heart Vienna on May 17th ➡️"Learnings from an optimised #TAVI patient's journey" on May 18th Sponsored post by Edwards Lifesciences

New multicenter TOPAS CMR study led by Miho.Fukui and Philippe Pibarot demonstrates the importance of phenotyping myocardial structural and function using #whyCMR in the complex group of low-gradient AS. Prognosis worsens with greater # of CMR risk markers. bit.ly/3yZGBr3

In Low Gradient AS, reduced GLS, increased ECV and LGE on CMR was associated with worse outcomes. Comprehensive myocardial characterization using cardiac magnetic resonance associates with outcomes in low gradient severe aortic stenosis academic.oup.com/ehjcimaging/ad…

Grateful to Luigi for invitation to write bit.ly/TR_Review_EACVI Together w/ Denisa Muraru Philipp E. Bartko francesco maisano Pepe Zamorano and Donal European Society of Cardiology Journals EACVI President European Society of Cardiology American Society of Echocardiography Ritu Thamman MD Dr. Gilbert Tang American College of Cardiology Columbia Valve Center @GeraldMaurer